Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2017 Jul 17;24(11):3180–3187. doi: 10.1245/s10434-017-6007-z

Table 3.

Summary statistics for ERAS vs no ERAS subgroup. All patients had PVB.

Summary Statistics ERAS
ERAS (n=19) No ERAS (n=47) p
Mean SD Mean SD
Age (y) 49.8  ±  6.7 49.0  ±  9.3 0.65
Weight (kg) 77.3  ±  15.3 79.1  ±  13.6 0.65
Pre-op MAP (mmHg) 82.8  ±  8.2 90.9  ±  15.7 0.01
Pre-op SBP (mmHg) 117.7  ±  9.8 131.6  ±  21.9 0.01
Pre-op DBP (mmHg) 72.5  ±  8.9 78.8  ±  14.0 0.07
Pre-op HR 76.4  ±  13.2 80.1  ±  13.2 0.30
Preop Crystalloid (mL) 415.1 167.5 374.4 261.7 0.45
ASA Class 0.10
1 0.0 0.0 6.0 0.1
2 16.0 0.8 39.0 0.8
3 3.0 0.2 2.0 0.0
EBL (mL) 115.8  ±  103.3 90.9  ±  87.8 0.34
Case Duration (min) 473.4  ±  8.5 471.3  ±  11.1 0.45
Bilateral, n (%) 12 (63%) 26 (55%) 0.60
% DIEP, n (%) 15 (79%) 40 (85%) 0.72
Delayed recon, n (%) 15 (79%) 36 (77%) 1